Antimuscarinics
Antimuscarinics
Antimuscarinics, also known as anticholinergics, are a class of drugs that block the action of the neurotransmitter acetylcholine at muscarinic receptors in the central and peripheral nervous system. These agents are used in a variety of clinical settings, including the treatment of overactive bladder, chronic obstructive pulmonary disease (COPD), and certain types of poisoning.
Mechanism of Action[edit | edit source]
Antimuscarinics work by competitively inhibiting the binding of acetylcholine to muscarinic receptors. These receptors are G protein-coupled receptors that mediate various physiological functions, such as smooth muscle contraction, glandular secretion, and modulation of heart rate. By blocking these receptors, antimuscarinics reduce parasympathetic nervous system activity, leading to effects such as bronchodilation, decreased secretions, and relaxation of smooth muscles.
Clinical Uses[edit | edit source]
Overactive Bladder[edit | edit source]
Antimuscarinics are commonly used to treat overactive bladder, a condition characterized by urinary urgency, frequency, and incontinence. Drugs such as oxybutynin, tolterodine, and solifenacin are frequently prescribed for this purpose.
Respiratory Disorders[edit | edit source]
In the management of COPD and asthma, antimuscarinics like ipratropium and tiotropium are used to achieve bronchodilation and improve airflow.
Gastrointestinal Disorders[edit | edit source]
Antimuscarinics can be used to treat gastrointestinal disorders such as irritable bowel syndrome (IBS) by reducing smooth muscle spasms and decreasing bowel motility.
Poisoning[edit | edit source]
In cases of organophosphate poisoning, which leads to excessive cholinergic activity, antimuscarinics such as atropine are used as antidotes to counteract the effects.
Side Effects[edit | edit source]
Common side effects of antimuscarinics include dry mouth, blurred vision, constipation, urinary retention, and confusion, especially in the elderly. These effects are due to the widespread distribution of muscarinic receptors throughout the body.
Contraindications[edit | edit source]
Antimuscarinics should be used with caution in patients with conditions such as glaucoma, myasthenia gravis, and urinary retention, as they can exacerbate these conditions.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD